• Tessera Defense issued 3,473,039 restricted common shares in unregistered transactions from Oct. 6 to Oct. 12, 2026.
• Issued 195,000 shares to Mayers Ventures for an equity stake in Israel-based M.E.A. Testing Systems, including an option on remaining ownership.
• Issued 3,278,039 shares to Mandragola via cashless exercises of a five-year warrant tied to Tessera’s 60% acquisition of Dr. Frucht Systems.
• Common shares outstanding totaled 13,983,094 as of Oct. 12, 2026, including shares sold through the at-the-market program.
• Net proceeds from the at-the-market program exceeded $6 million through Oct. 12 at an average net price of about $1.11 per share.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tessera Defense and Homeland Security Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-109087), on October 13, 2026, and is solely responsible for the information contained therein.